Paraganglioma in The Urinary Bladder: A Pitfall in Histopathologic Diagnosis

Jamie Lim Co, Maria Lourdes Luna Goco, Jeffrey Santos So


Paraganglioma of the urinary bladder is a rare neuroendocrine tumor which originates from the chromaffin tissue of the sympathetic nervous system. It only accounts for about 0.05% of all vesical tumors. Bladder paraganglioma may also present with non-specific symptoms which could easily lead to misdiagnosis. In this report, emphasis on the histomorphology and immunohistochemical profile of the tumor is stressed as the morphological findings could overlap with relatively more common urothelial neoplasms. Distinction from other tumors is of utter importance because of different therapeutic options. Here, we present a case of a 52 year-old, filipino, male, previously diagnosed with colonic tubulovillous adenoma, presenting with dysuria and hematuria who, after undergoing CT Stonogram revealed an incidental finding of a lobulated mass measuring 5.7 cm located at the anteroinferior portion of the urinary bladder wall.


Paraganglioma; pitfall; urinary bladder; diagnosis


Humphrey P, Ulbright T, Reuter V, Moch H. Neuroendocrine tumours. WHO classification of tumours of the urinary system and male genital organs. essay, International Agency for Research on Cancer. 2016.

Zimmerman IJ, Biron RE, MacMahon HE. Pheochromocytoma of the urinary bladder. New England Journal of Medicine. 1953;249(1):25–6. doi:10.1056/nejm195307022490106

Ghafoor AU, Yousaf I, Pervez R, Khan RU, Mir K. Paraganglioma of urinary bladder: an unusual presentation. Pitfalls in diagnosis and treatment. J Pak Med Assoc. 2012;62(1):63-5.

Saha A, Saha K, Sarkar N, Geelani IA. Paraganglioma of urinary bladder: An uncommon entity in uropathology. Cureus. 2021;13(8):e17265.

Zhou M, Epstein JI, Young RH. Paraganglioma of the urinary bladder. Am J Surg Pathol. 2004;28(1):94–100.

Male M, Ye T, Tao J, Chen Z-qiang, Peng E. Differentiating nonfunctional paraganglioma of the bladder from urothelial carcinoma of the bladder: Pitfalls and breakthroughs. BioMed Research International, 2019;1–7.

So JS, Epstein JI. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol. 2013;26(10):1365-70. doi: 10.1038/modpathol.2013.76. Epub 2013 Apr 19. PMID: 23599157.

Manger WM, Gifford RW. Diagnosis in clinical and experimental pheochromocytoma. Cambridge: Black well Science; 1996:205-332.

Goldblum JR, Lamps LW, McKenney JK, Myers JL, Ackerman LV, Rosai J. Rosai and Ackerman’s surgical pathology. 2018.

Al-Zahrani AA. Recurrent urinary bladder paraganglioma. Advances in Urology. 2010:912125.

Kurose H, Ueda K, Uegaki M, et al. Paraganglioma of the urinary bladder: Case report and literature review. IJU Case Reports. 2020;3(5):192–5.

Iwamoto G, Kawahara T, Tanabe M, et al. Paraganglioma in the bladder: a case report. Journal of Medical Case Reports. 2017;11(1):306.

Loveys FW, Pushpanathan C, Jackman S. Urinary bladder paraganglioma. Radio Graphics. 2015;35(5): 1433–8.

Li H, Xie J, Chen Z, Yang S, Lai Y. Diagnosis and treatment of a rare tumor-bladder paraganglioma. Molecular and Clinical Oncology. 2020;13:40.

Priyadarshi V, Pal DK. Paraganglioma of urinary bladder. Urology annals. 2015;7(3):402–4.

Kumar V, Abbas AK, Aster JC. Robbins and Cotran pathologic basis of disease. Ninth edition. Philadelphia, PA: Elsevier/Saunders; 2015.

Bejrananda T, Sawasdee A, Boonchai S, Tanthanuch M. Primary malignant melanoma of the bladder: A rare case report in Asia and review of the literature. Res Rep Urol. 2021;13:833-9.

Yuan Y, Su Z, Zhu R, Li X, Xu G. Bladder paraganglioma: Three cases report and literature review. International Medical Case Reports Journal. 2021;14:765–71.

Snajdar E, Ajo AR, Rosen K, et al. Primary malignant melanoma of the urinary bladder. Cureus. 2021;13(3): e14067.

Karabulut YY, Erdogan S, Sayar H, Ergen A, Ertoy Baydar D. Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases. Melanoma Res. 2016;26(6):616-24. doi: 10.1097/CMR.0000000000000300. PMID: 27603550.

Nerli RB, Ghagane SC, Ram P, Shimikore SS, Vinchurkar K, Hiremath MB. Bladder invasion in patients with advanced colorectal carcinoma. Indian Journal of Surgical Oncology. 2018;9(4):547–51.

Eldar S, Kemeny MM, Terz JJ. Extended resections for carcinoma of the colon and rectum. Surg Gynecol Obstet. 1985;161(4):319–22.

Kobayashi T, Kamoto T, Sugino Y, Takeuchi H, Habuchi T, Ogawa O. High incidence of urinary bladder involvement in carcinomas of the sigmoid and rectum: a retrospective review of 580 patients with colorectal carcinoma. J Surg Oncol. 2003;84(4):209–14.

Carne PWG, Frye JNR, Kennedy-Smith A, et al. Local invasion of the bladder with colorectal cancers: surgical management and patterns of local recurrence. Dis Colon Rectum. 2004;47(1):44–7.

Magnusson K, de Wit M, Brennan DJ, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011;35(7):937-48. doi: 10.1097/PAS.0b013e31821c3dae. PMID: 21677534.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.